SPECIALIST/PHYSICIAN/RESEARCHER/ INDUSTRY/CORPORATE STAFF |
Early Bird Rate (USD) Ends 31 Aug 2024 |
Regular Rate (USD) 1 Sep to 20 Sep |
On-site Rate (USD) 30 Oct-2 Nov |
---|---|---|---|
A: PACTRIMS-ECTRIMS TEACHING COURSE, 30 October 2024 (1 Day) | USD 150 | USD 150 | USD 250 |
B: PACTRIMS CONGRESS, 31 Oct-2 Nov (3 days) | USD 550 | USD 650 | USD 750 |
A+B: Combined PACTRIMS-ECTRIMS Teaching Course and Main Congress, 30 Oct-2 Nov (4 days) | USD 650 | USD 750 | USD 850 |
POST GRADUATE STUDENT/TRANING NEUROLOGIST/NURSE/ALLIED HEALTH PROFESSIONAL/PHARMACIST* |
Early Bird Rate (USD) Ends 31 Aug 2024 |
Regular Rate (USD) 1 Sep to 20 Sep |
On-site Rate (USD) 30 Oct-2 Nov |
---|---|---|---|
A: PACTRIMS-ECTRIMS TEACHING COURSE, 30 October 2024 (1 Day) | USD 150 | USD 150 | USD 250 |
B: PACTRIMS CONGRESS, 31 Oct-2 Nov (3 days) | USD 300 | USD 300 | USD 400 |
A+B: Combined PACTRIMS-ECTRIMS Teaching Course and Main Congress, 30 Oct-2 Nov (4 days) | USD 350 | USD 350 | USD 500 |
In an effort to forge a diversified MS community within the Asia Pacific Region, the PACTRIMS Travel Grant contributes funds to qualifying individuals’ travel expenses for Congress participation. This is done to encourage participation from healthcare professionals in the Asia Pacific Region, increasing the prominence and importance of research and interest in Multiple Sclerosis (MS) in the Region and encourage mutually beneficial interaction among MS healthcare professionals.
Eligibility
To qualify, individuals must satisfy the following criteria.
LOW-INCOME ECONOMIES
LOWER-MIDDLE INCOME ECONOMIES
Travel Grant Award Description
The PACTRIMS Travel Grant of USD$ 1,000 is only available to the first 25 applicants; and these applicants must not be Thai residents and PR residing in Thailand. A photocopy of your passport showing your name and nationality and a declaration as proof of five years or less experience as a healthcare professional is required and must be signed by the Head of Department or Institution with your Institution original letterhead. Applicants who are non-Thai citizens but practice in Thailand are not eligible for the grant.
Citizens of Iran, Syria, Crimea, North Korea and Cuba are not eligible for the Travel Grant.
Instructions
Qualifying individuals must fill out an application form available for download ONLINE or from the registration desk during the Congress from 30 October to 2 November 2024.
The following items are important and compulsory in your submission:
Payment
The grant will be credited to qualifying individuals via telegraphic transfer within 90 days after the end of the PACTRIMS Congress. Please provide complete and accurate bank details or PACTRIMS will deduct bank charges of USD$50 for every unsuccessful attempt.
Please note that after 2 unsuccessful attempts, PACTRIMS will rescind and cancel the travel grant.
Submission Deadline
Completed applications and accompanying documents must be received by the Secretariat on or before the last day of the Congress, 2 November 2024 by 10.00am Thailand local time. Late submissions will not be entertained and please adhere strictly to this deadline.
09:00 - 09:05 | Welcome to the Inaugural PACTRIMS-ECTRIMS Joint Teaching Course |
Todd Hardy (Australia) Jyh Yung Hor (Malaysia) Waqar Rashid (UK) |
Chairpersons: Todd Hardy (Australia) & Waqar Rashid (UK)
09:05 - 09:40 | TL1: Diagnosis of MS - Update on the McDonald criteria | Waqar Rashid (UK) |
09:40 - 10:15 | TL2: How to treat MS - including discontinuation/de-escalation | Vincent Van Pesch (Belgium)
|
Chairpersons: Simon Ling (Singapore) & Cheryl Hemingway (UK)
10:45 - 11:20 | TL3: Challenges of MS in childhood and adolescence | Cheryl Hemingway (UK) |
11:20 - 11:55 | TL4: Approach to Optic Neuritis | Shweta Singhal (Singapore) |
11:55 - 12:30 | TL5: MS Nursing Lecture: Vascular Co-Morbidities in MS | Meaghan Osborne (Australia) |
12:30 - 13:30 | Skyline Restaraunt (11th Floor) |
Chairpersons: Sean Riminton (Australia) & Martina Absinta (Italy)
13:30 - 14:05 | TL6: Pathology of MS | Richard Reynolds (UK) |
14:05 - 14:40 | TL7: Immunology of MS | Sean Riminton (Australia) |
14.40 - 15:15 | TL8: MS Biomarkers - including newer MRI techniques and the role of neurofilaments | Martina Absinta (Italy) |
Chairpersons: Jyh Yung Hor (Malaysia) & Ichiro Nakashima (Japan)
15:45 - 16:20 | TL9: Diagnosis and Treatment of NMOSD | Jin Nakahara (Japan) |
16:20 - 16:55 | TL:10 Diagnosis and Treatment of MOGAD | Ichiro Nakashima (Japan) |
Todd Hardy (Australia), Jyh Yung Hor (Malaysia), Waqar Rashid (UK)
Chairpersons: Giancarlo Comi (Italy) & Kazuo Fujihara (Japan)
12:30-13:00 |
Treatment of progressive MS in practice |
Hans-Peter Hartung (Germany) |
13:00-13:30 |
Patient Reported outcomes in the assessment of treatment response |
Giancarlo Comi (Italy) |
13:30-14:00 |
Advances in neurorehabilitation |
Letizia Leocani (Italy) |
14:00-14:30 |
Symptomatic therapy |
Kazuo Fujihara (Japan) |
14:45-14:50 | Welcome Address by the Local Organizing Chairperson | Sasitorn Siritho (Thailand) |
14:50-14:55 | Opening Address by the President | Kazuo Fujihara (Japan) |
14:55-15:00 | Special Address by the Guest of Honour | Deputy Director General Dr. Sakarn Bunnag (Thailand) |
Chairpersons: Jen Jen Su (Taiwan) & Sungmin Kim (Korea)
15:00-15:25 | L1. Correlation of neuropatholgy with MRI | Martina Absinta (Italy) |
15:25-15:50 | L2. Pathomechanisms of NMOSD | Norio Chihara (Japan) |
15:50-16:15 | L3. Meningeal inflammation as a driver of cortical pathology in Multiple Sclerosis | Richard Reynolds (UK) |
16:15-16:30 | Q&A |
16:30-17:00 | Giancarlo Comi |
Chairpersons: Hans Peter Hartung (Germany) & Sasitorn Siritho (Thailand)
17:00 - 18:00 | Oral Presentation |
Chairpersons: Jin Nakahara (Japan)
18:15-19:15 |
How Satralizumab changed treatment strategy in NMOSD |
Yusei Miyazaki (Japan) Ichiro Nakashima (Japan) |
08:00-09:00 |
Complement in Focus: Clinical and Real-World Evidence for the Prevention of Relapses in AQP4-Ab+ NMOSD |
Prof. Ho Jin Kim (Korea) Prof. Sasitorn Siritho (Thailand) Prof. Jin Nakahara (Japan) |
Chairpersons: Lekha Pandit (India) & Todd Hardy (Australia)
9:15-9:40 | L4. Pediatric MS/NMOSD | Cheryl Hemingway (UK) |
9:40-10:05 | L5. Prevalence and Diagnosis of Pediatric MS/NMOSD in Taiwan | Wang-Tso Lee (Taiwan) |
10:05-10.20 | Q&A |
10:20 - 10:50 | Hans-Peter Hartung |
Chairpersons: Ichiro Nakashima (Japan) & Kevin Tan (Singapore)
10:50-11:15 | L6. RIS and its revised criteria | Darin Okuda (USA) |
11:15-11:40 | L7. Importance of early diagnosis of MS and predict early non-disabling relapses | Anneke van der Walt (Australia) |
11:40-12:05 | L8. Diagnosis of MOGAD: Tips for accurate diagnosis | Jae-Won Hyun (Korea) |
12:05-12:20 | Q&A |
12:20 - 13:20 | Skyline Restaraunt (11th Floor) |
Chairpersons: Kazuo Fujihara (Japan) & Allan Kermode (Australia)
13:20 - 14:20 | Oral Presentations |
Chairpersons: Metha Apiwattanakul (Thailand) & Thomas Mathew (India)
14:20-14:45 | L9. Treatment strategy for PML in daily practice | Jin Nakahara (Japan) |
14:45-15:10 | L10. Risk mitigation in multiple sclerosis immunotherapy - the Indian perspective | Sruthi Nair (India) |
15:10-15:35 | L11. Treatment strategies for MS/NMOSD in Thailand | Metha Apiwattanakul (Thailand) |
15:35-15:50 | Q&A |
Chairperson: Letizia Leocani (Italy)
16:05 - 17:30 | Poster Presentation Session |
Chairperson Kazuo Fujihara (Japan)
17:30-18:30 |
CD19-targeted therapy for NMOSD |
Chung-Hsing Chou (Taiwan) Yusei Miyazaki (Japan) |
Chairpersons: Yaou Liu (China) & Yeo Tianrong (Singapore)
9:45-10:10 | L12. Overview of machine learning approaches | Wilson Goh (Singapore) |
10:10-10:35 | L13. Future with AI-based MRI monitoring in MS | Chenyu (Tim) Wang (Australia) |
10:35-11:00 | L14. AI for imaging MS and NMOSD | Yaou Liu (China) |
11:00-11:15 | Q&A |
11:15-11.30 | Poster Award ceremony | Noriko Isobe (Japan) |
11:30-11.35 | Closing Remarks by the Vice-President | Ho Jin Kim (Korea) |
Associate Professor of Neurology
at Humanitas University in Milan
Head of the Neuroimmunology Unit, Department of Neurology, Neurological Institute of Thailand
Project Associate Professor of Neurology
at Kobe University Hospital
Honorary Professor Vita Salute San Raffaele University (Milan)
Professor, Department of Multiple Sclerosis Therapeutics, Fukushima Medical University School of Medicine, Fukushima, Japan
Assistant Professor of Biomedical Informatics, Lee Kong Chian School of Medicine, School of Biological Sciences
Professor of Neurology
Heinrich Heine University Düsseldorf, Germany
Consultant Neurologist, GOSH
Hon Ass Professor Institute of Child Health, University College London
Neurologist, Assistant Professor,
National Cancer Center
Associate Professor of Neurology
University Vita-Salute San Raffaele, Milan
Superintendent,
National Taiwan University Children’s Hospital, Taipei, Taiwan
Director of Department of Radiology,
Beijing Tiantan Hospital, Capital Medical University
Additional Professor, Department of Neurology,
Sree Chitra Tirunal Institute for Medical Sciences and Technology
Professor and Chair of the Department of Neurology,
Keio University School of Medicine
Professor of Neurology at Tohoku Medical and Pharmaceutical University
Professor of Neurology
Neurology and Stroke Nurse Practitioner, Royal Brisbane and Women’s Hospital
Consultant Neurologist St George’s University Hospitals NHS Foundation Trust
Professor of Cellular Neurobiology, Faculty of Medicine, Division of Brain Sciences,
Imperial College London, UK
Head of Department of Immunology and Cofounder of the Neuroimmunology Service at Concord Hospital in Sydney
Senior Consultant, Department of Neuro Ophthalmology, Singapore National Eye Centre(SNEC)
Director of the Multiple Sclerosis and Neuroimmunology Unit and Neuro-ophthalmology Service, Alfred Health, Melbourne
Associate Chief of Neurology Department, Cliniques Universitaires Saint-Luc,
UCLouvain University, Brussels, Belgium
MS Australia Fellow, Senior Research Fellow, University of Sydney